Skip to main content
. 2017 Nov 16;8(63):106468–106474. doi: 10.18632/oncotarget.22474

Table 2. Univariable and multivariable model for OS.

Variable Univariable HR
(95% CI)
P-value Multivariable HR
(95% CI)
P-value
WHO PS 1.57 (1.16–2.13) 0.004 1.49 (1.04–2.13) 0.028 (1 vs 0)
Time since last therapy (>6 mths) 0.59 (0.44–0.79) <0.001
Neutropenia (Gr.3/4) 0.67 (0.50–0.90) 0.007
Hb (mmol/L) 0.57 (0.49–0.67) <0.001 0.73 (0.61–0.87) 0.001
PSA (log, g/L) 1.12 (1.01–1.26) 0.040
AP (log, U/L) 1.83 (1.49–2.25) <0.001 1.50 (1.18–1.19) 0.001
LDH (log, U/L) 2.37 (1.73–3.25) <0.001
Albumin (g/L) 0.91 (0.89–0.94) <0.001 0.92 (0.89–0.95) <0.001

Univariable N = 206–224 (because of missing values the number of included patients can differ per variable) Multivariable N = 200.

Abbreviations: WHO PS = world health organization performance status, Hb = hemoglobin, PSA = prostate specific antigen, AP = alkaline phosphatase, LDH = lactate dehydrogenase, log = log transformed variables when data were not normally distributed.